A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease

  • Leong, Rupert (Primary Chief Investigator)
  • Butala, Radhika (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Parshionikar, Abhijit (Clinical Trial Unit Staff)
  • Rajasekharan Nair, Archana (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleGALAXI
AcronymGALAXI
StatusActive
Effective start/end date30/09/197/05/24